OxThera Receives Positive Decision From EMA on Paediatric Investigational Plan (PIP) for Treatment o

STOCKHOLM, Sweden, Aug. 23, 2019 /PRNewswire/ -- OxThera AB, a privately-held biopharmaceutical company dedicated to improving the lives of people with Primary ... Lees verder

Bron:

ANP Pers support